Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis

Published:2018-03-25 Issue:1 Volume:24 Page:61-76
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Ando Wataru,Yokomori Hiroaki,Tsutsui Nobuhiro,Yamanouchi Eigoro,Suzuki Yutaka,Oda Masaya,Inagaki Yutaka,Otori Katsuya,Okazaki Isao

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://e-cmh.org/upload/pdf/cmh-2017-0030.pdf

Reference39 articles.

1. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

2. Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease

3. Human Fatty Liver Disease: Old Questions and New Insights

4. Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD—A Pilot Study;Nutrients;2024-05-02

2. Matrix metalloproteinases and morphological features in chronic liver diseases;Experimental and Clinical Gastroenterology;2024-03-15

3. 3D microscaffolds with triple-marker sensitive nanoprobes for studying fatty liver disease in vitro;Nanoscale;2024

4. NONINVASIVE PROTEOMIC BIOMARKER IN DISORDERS OF THE NONALCOHOLIC FATTY LIVER;NEW ARMEN MED J;2024

5. THE ROLE OF EVOLVING TECHNIQUES AND PROSPECTIVE IMPLICATIONS OF BIOMARKERS IN LIVER DISEASE;NEW ARMEN MED J;2024